» Articles » PMID: 18495950

Vitamin K-dependent Proteins, Warfarin, and Vascular Calcification

Overview
Specialty Nephrology
Date 2008 May 23
PMID 18495950
Citations 80
Authors
Affiliations
Soon will be listed here.
Abstract

Vitamin K-dependent proteins (VKDPs) require carboxylation to become biologically active. Although the coagulant factors are the most well-known VKDPs, there are many others with important physiologic roles. Matrix Gla Protein (MGP) and Growth Arrest Specific Gene 6 (Gas-6) are two particularly important VKDPs, and their roles in vascular biology are just beginning to be understood. Both function to protect the vasculature; MGP prevents vascular calcification and Gas-6 affects vascular smooth muscle cell apoptosis and movement. Unlike the coagulant factors, which undergo hepatic carboxylation, MGP and Gas-6 are carboxylated within the vasculature. This peripheral carboxylation process is distinct from hepatic carboxylation, yet both are inhibited by warfarin administration. Warfarin prevents the activation of MGP and Gas-6, and in animals, induces vascular calcification. The relationship of warfarin to vascular calcification in humans is not fully known, yet observational data suggest an association. Given the high risk of vascular calcification in those patients with chronic kidney disease, the importance of understanding warfarin's effect on VKDPs is paramount. Furthermore, recognizing the importance of VKDPs in vascular biology will stimulate new areas of research and offer potential therapeutic interventions.

Citing Articles

Vitamin K Properties in Stroke and Alzheimer's Disease: A Janus Bifrons in Protection and Prevention.

Grimaldi L, Cavallaro R, De Angelis D, Fuso A, Sancesario G Molecules. 2025; 30(5).

PMID: 40076254 PMC: 11901974. DOI: 10.3390/molecules30051027.


Mechanisms of Cardiovascular Calcification and Experimental Models: Impact of Vitamin K Antagonists.

Siracusa C, Carino A, Carabetta N, Manica M, Sabatino J, Cianflone E J Clin Med. 2024; 13(5).

PMID: 38592207 PMC: 10932386. DOI: 10.3390/jcm13051405.


Cytochrome P450 Family and Haplotype Mapping and Association with Hepatic Gene Expression and Vitamin K Hydroxylation Activity.

Alade A, Claw K, McDonald M, Prasad B, Rettie A, Thummel K ACS Pharmacol Transl Sci. 2024; 7(3):716-732.

PMID: 38481683 PMC: 10928895. DOI: 10.1021/acsptsci.3c00287.


Pharmacogenomic Considerations for Anticoagulant Prescription in Patients with Hereditary Haemorrhagic Telangiectasia.

McCarley S, Murphy D, Thompson J, Shovlin C J Clin Med. 2023; 12(24).

PMID: 38137783 PMC: 10744266. DOI: 10.3390/jcm12247710.


Vitamin K and Calcium Chelation in Vascular Health.

Aaseth J, Alehagen U, Opstad T, Alexander J Biomedicines. 2023; 11(12).

PMID: 38137375 PMC: 10740993. DOI: 10.3390/biomedicines11123154.


References
1.
Nakano T, Kawamoto K, Kishino J, Nomura K, Higashino K, Arita H . Requirement of gamma-carboxyglutamic acid residues for the biological activity of Gas6: contribution of endogenous Gas6 to the proliferation of vascular smooth muscle cells. Biochem J. 1997; 323 ( Pt 2):387-92. PMC: 1218331. DOI: 10.1042/bj3230387. View

2.
Saller F, Burnier L, Schapira M, Angelillo-Scherrer A . Role of the growth arrest-specific gene 6 (gas6) product in thrombus stabilization. Blood Cells Mol Dis. 2006; 36(3):373-8. DOI: 10.1016/j.bcmd.2005.12.038. View

3.
Wallin R, Cain D, Sane D . Matrix Gla protein synthesis and gamma-carboxylation in the aortic vessel wall and proliferating vascular smooth muscle cells--a cell system which resembles the system in bone cells. Thromb Haemost. 1999; 82(6):1764-7. View

4.
El-Abbadi M, Giachelli C . Mechanisms of vascular calcification. Adv Chronic Kidney Dis. 2007; 14(1):54-66. DOI: 10.1053/j.ackd.2006.10.007. View

5.
Spronk H, Soute B, Schurgers L, Thijssen H, De Mey J, Vermeer C . Tissue-specific utilization of menaquinone-4 results in the prevention of arterial calcification in warfarin-treated rats. J Vasc Res. 2003; 40(6):531-7. DOI: 10.1159/000075344. View